Cargando…
ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth
ANLN is frequently upregulated in triple-negative breast cancer (TNBC) and its high expression in tumors are significantly associated with poor survival and recurrence, thereby it has been proposed to function as a prognostic marker for breast cancer. However, the specific function and molecular mec...
Autores principales: | Maryam, Alishba, Chin, Y. Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280772/ https://www.ncbi.nlm.nih.gov/pubmed/34277708 http://dx.doi.org/10.3389/fmolb.2021.700973 |
Ejemplares similares
-
Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022) -
The application of exosomes in the treatment of triple-negative breast cancer
por: Weaver, John W., et al.
Publicado: (2022) -
Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
por: Aguilar Cosme, Jose R., et al.
Publicado: (2021) -
Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma
por: Wu, Shafei, et al.
Publicado: (2021) -
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
por: Ribeiro, Rita, et al.
Publicado: (2022)